>
Baxter International Inc logo

BAX - Baxter International Inc Share Price

$84.54 -0.4  -0.4%

Last Trade - 12/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £31.12bn
Enterprise Value £32.94bn
Revenue £8.50bn
Position in Universe 295th / 6841
Bullish
Bearish
Unlock BAX Revenue
Momentum
Relative Strength (%)
1m +4.24%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9,968 10,163 10,584 11,099 11,362 11,673 12,528 13,205 +3.2%
+32.8 +124.4 -17.9 -2.2 +16.6 -0.6 +20.5 +17.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BaxterInternational Inc revenues increased 3% to $11.67B. Netincome before extraordinary items increased 37% to $1.1B.Revenues reflect APAC segment increase of 8% to $2.48B,EMEA segment increase of 5% to $3.13B. Net income benefitedfrom APAC segment income increase of 8% to $591M, EMEAsegment income increase of 4% to $677M. Dividend per shareincreased from $0.85 to $0.96.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BAX
Graphical History

Revenue

BAX Revenue Unlock BAX Revenue

Net Income

BAX Net Income Unlock BAX Revenue

Normalised EPS

BAX Normalised EPS Unlock BAX Revenue

PE Ratio Range

BAX PE Ratio Range Unlock BAX Revenue

Dividend Yield Range

BAX Dividend Yield Range Unlock BAX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BAX EPS Forecasts Unlock BAX Revenue
Profile Summary

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated October 19, 1931
Public Since May 15, 1961
No. of Shareholders: 22,017
No. of Employees: 50,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 505,772,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BAX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BAX
Upcoming Events for BAX
Thursday 29th April, 2021
Q1 2021 Baxter International Inc Earnings Release
Thursday 29th April, 2021
Q1 2021 Baxter International Inc Earnings Call
Tuesday 4th May, 2021
Baxter International Inc Annual Shareholders Meeting
Wednesday 5th May, 2021 Estimate
Baxter International Inc Annual Shareholders Meeting
Tuesday 11th May, 2021
Baxter International Inc at Bank of America Global Research Healthcare Conference (Virtual)
Wednesday 28th July, 2021 Estimate
Q2 2021 Baxter International Inc Earnings Release
Frequently Asked Questions for Baxter International Inc
What is the Baxter International Inc share price?

As of 12/04/21, shares in Baxter International Inc are trading at $84.54, giving the company a market capitalisation of £31.12bn. This share price information is delayed by 15 minutes.

How has the Baxter International Inc share price performed this year?

Shares in Baxter International Inc are currently trading at $84.54 and the price has moved by -2.7% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Baxter International Inc price has moved by -34.92% over the past year.

What are the analyst and broker recommendations for Baxter International Inc?

Of the analysts with advisory recommendations for Baxter International Inc, there are there are currently 5 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Baxter International Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Baxter International Inc next release its financial results?

Baxter International Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Baxter International Inc dividend yield?

The Baxter International Inc dividend yield is 1.13% based on the trailing twelve month period.

Does Baxter International Inc pay a dividend?

Last year, Baxter International Inc paid a total dividend of 0.96, and it currently has a trailing dividend yield of 1.13%. Looking ahead, Baxter International Inc has not announced an ex-dividend date yet.

When does Baxter International Inc next pay dividends?

Baxter International Inc has yet to annouce their ex-dividend date. The historic dividend yield on Baxter International Inc shares is currently 1.13%.

How do I buy Baxter International Inc shares?

To buy shares in Baxter International Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Baxter International Inc?

Shares in Baxter International Inc are currently trading at $84.54, giving the company a market capitalisation of £31.12bn.

Where are Baxter International Inc shares listed? Where are Baxter International Inc shares listed?

Here are the trading details for Baxter International Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: BAX
What kind of share is Baxter International Inc?

Based on an overall assessment of its quality, value and momentum, Baxter International Inc is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Baxter International Inc share price forecast 2021?

Shares in Baxter International Inc are currently priced at $84.54. At that level they are trading at 8.53% discount to the analyst consensus target price of 0.00.

Analysts covering Baxter International Inc currently have a consensus Earnings Per Share (EPS) forecast of 3.402 for the next financial year.

How can I tell whether the Baxter International Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Baxter International Inc. Over the past six months, the relative strength of its shares against the market has been -10.89%. At the current price of $84.54, shares in Baxter International Inc are trading at 4.18% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Baxter International Inc PE Ratio?

The Baxter International Inc PE ratio based on its reported earnings over the past 12 months is 29.94. The shares are currently trading at $84.54.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Baxter International Inc?

Baxter International Inc's management team is headed by:

James Gavin - IND
John Forsyth - IND
Albert Stroucken - LED
Peter Hellman - IND
Jeanne Mason - SVP
Thomas Chen - IND
Jose Almeida - CHM
James Saccaro - CFO
Sean Martin - SVP
Giuseppe Accogli - SVP
Cristiano Franzi - SVP
Andrew Frye - SVP
Jacqueline Kunzler - SVP
James Borzi - SVP
Who are the major shareholders of Baxter International Inc?

Here are the top five shareholders of Baxter International Inc based on the size of their shareholding:

Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 8.18% (41.4m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.75% (39.2m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.44% (27.5m shares)
Morgan Stanley Investment Management Ltd. (UK) Investment Advisor
Percentage owned: 4.47% (22.6m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.16% (21.1m shares)
Similar to BAX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.